Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Feen Biotechnology is a specialized biotechnology service provider headquartered in Wuhan, China, focusing on high-resolution multi-omics technologies. The company offers a comprehensive suite of services including single-cell RNA sequencing (scRNA-seq), spatial transcriptomics, and advanced bioinformatics analysis. By utilizing cutting-edge platforms such as 10x Genomics Visium and BGI Stereo-seq, Feen Bio provides researchers with detailed insights into cellular heterogeneity and tissue microenvironments. Their expertise extends to various biological applications, supporting studies in oncology, immunology, neurology, and developmental biology. Feen Bio serves a diverse clientele comprising academic research institutions, clinical hospitals, and pharmaceutical R&D departments. The company is recognized for its robust data processing pipelines and its ability to deliver high-quality, publication-ready genomic data.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Feen Biotechnology.